This is a very common question, so let’s get straight to it.

With support from the Cross-Border Threat Screening and Supply Chain Defense Center of Excellence, Biomeme and Predigen were proud to recently...

EDIT: As RNA viruses like SARS-CoV-2 continue to mutate, so will this panel. Please review our COVID-19 page for the latest information regarding our...

Biomeme has officially outgrown its home at 10th and Chestnut and is moving on to Netrality’s 401 North Broad Street for its new corporate...

As the world crosses the 1-year mark since the World Health Organization classified COVID-19 as a pandemic, testing is still as crucial as ever. The...

The Partnership

Back in May 2019, Biomeme and INDICAL Bioscience entered into an exclusive global licensing and research agreement in a joint effort...

We are thrilled to announce Biomeme, Inc. has been awarded a Redevelopment Assistance Capital Program (RACP) grant of $3 million from the...

List of SARS-CoV-2 Variants & Classifications

Biomeme continuously monitors and analyzes sequences of emerging variants of concern and updates this...

The finalists have been announced and Biomeme is moving forward to the next round of XPRIZE Rapid COVID Testing, a $6 million dollar 6-month...